Curian Capital’s Labcorp LH Stock Holding History

Curian Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-67,241	Closed	-$5.78M	–	582
2013 Q2	$5.78M	Buy	+67,241	New	+$5.58M	0.1%	181

Other funds holding LH

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Curian Capital's LH Position: Q3 2013 in Review

Curian Capital sold out of Labcorp (LH) in Q3 2013, closing a stake of 67,241 shares — an estimated $5.78M sold.

Curian Capital first reported a position in LH in Q2 2013 and held it in 1 quarter. The position peaked at $5.78M in Q2 2013. 498 funds tracked by Wall St. Rank hold LH as of Q3 2013.

Curian Capital reported no remaining Labcorp position as of Q3 2013 after selling out during the quarter.
Curian Capital sold 67,241 Labcorp shares in Q3 2013, an estimated $5.78M.
Curian Capital first reported a position in Labcorp in Q2 2013 and held it in 1 quarter.
Curian Capital's Labcorp position peaked at $5.78M in Q2 2013.
498 funds tracked by Wall St. Rank held Labcorp as of Q3 2013.

Based on Curian Capital's 13F filing for Q3 2013, filed 14 Nov 2013.